EUVIMEDEUVIMED entdecken
Open Access

Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement

Ding Zhang iD, Yunfei Xie, Qi Liao, Zhe Jiao, Rui Liang, Jintao Zhang, Yu Zhang, Yubei Tan, Huanbin Wang, Wanpo Zhang, Shaobo Xiao iD, Guiqing Peng iD und 1 weitere

Journal of Virology · 19.11.2024 · 98 (11)

DOI: 10.1128/jvi.00429-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 19.11.2024. Verfasst von Ding Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Vaccines, Attenuated, Swine Diseases, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine epidemic diarrhea (PED) has caused serious economic losses to the swine livestock industry. Due to the rapid variation in the PEDV) genome, especially the spike (S) protein, the cross-protection ability of antibodies between different vaccine strains is weakened. Hence, the rapid development of safe, broad-spectrum and highly effective attenuated PEDV vaccine still needs further research. Here, we found that the replacement of the S2 subunit had little effect on S protein immunogenicity. Moreover, the chimeric virus (YN-S2 DR13 ), the S protein of the YN strain was replaced by the DR13 S2 subunit, which lost its trypsin tropism and increased its propagation ability (approximately 1 titer) in Vero cells. Then, the pathogenesis of YN-S2 DR13 was evaluated in neonatal piglets. Importantly, quantitative real-time PCR, histopathology, and immunohistochemistry confirmed that the virulence of YN-S2 DR13 was significantly reduced compared with that of YN. Immunization with YN-S2 DR13 induced neutralizing antibodies against both YN and DR13 in weaned piglets. In vitro passaging data also showed that YN-S2 DR13 had good genetic stability. Collectively, these results suggest that YN-S2 DR13 has significant advantages as a novel vaccine candidate, including a capacity for viral propagation to high titers with no trypsin requirement and the potential to provide protection against both PEDV G1 and G2 strains infections. Our results also suggests that S2 subunit replacement using reverse genetics can be a rapid strategy for the rational design of live attenuated vaccines for PEDV. IMPORTANCE Emerging highly virulent porcine epidemic diarrhea virus (PEDV) G2 strains has caused substantial economic losses worldwide. Vaccination with a live attenuated vaccine is a promising method to prevent and control PED because it can induce a strong immune response (including T- and B-cell immunity). Previous studies have demonstrated that the S2 subunit of the PEDV spike (S) protein is the determinant of PEDV trypsin independence. Here, we evaluated the pathogenicity, tissue tropism, and immunogenicity of the chimeric virus (YN-S2 DR13 ) via animal experiments. We demonstrated that YN-S2 DR13 strain, as a trypsin independent strain, increased intracellular proliferation capacity, significantly reduced virulence, and induced broad-spectrum neutralization protection against PEDV G1 and G2 strains. In vitro passaging data also validated the stability of YN-S2 DR13 . Our results showed that generating a chimeric PEDV strain that is trypsin-independent by replacing the S2 subunit is a promising approach for designing a live attenuated vaccine for PEDV in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine epidemic diarrhea virusVaccines, AttenuatedSwine DiseasesSpike Glycoprotein, CoronavirusViral VaccinesCoronavirus InfectionsAntibodies, ViralAnimalsSwineVero CellsChlorocebus aethiopsAntibodies, NeutralizingVirulence

Stichwörter der Autor:innen

chimeric virusimmunogenicityporcine epidemic diarrhea virus (PEDV)spike proteinvirulence

Substanzen

Vaccines, AttenuatedSpike Glycoprotein, CoronavirusViral VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Department of Animal Nutrition and Feed Science College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, China.
  • Veterinary Pathology Laboratory, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.

ORCID-Profile: Ding Zhang, Shaobo Xiao, Guiqing Peng, Yuejun Shi

Förderung

  • MOST | National Key Research and Development Program of China (NKPs)

Zitieren

APA

Zhang, D., Xie, Y., Liao, Q., Jiao, Z., Liang, R., Zhang, J., Zhang, Y., Tan, Y., Wang, H., Zhang, W., Xiao, S., Peng, G., & Shi, Y. (2024). Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement. Journal of Virology, 98(11). https://doi.org/10.1128/jvi.00429-24

Vancouver

Zhang D, Xie Y, Liao Q, Jiao Z, Liang R, Zhang J, et al. Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement. Journal of Virology. 2024;98(11). doi:10.1128/jvi.00429-24

BibTeX
@article{Zhang2024,
  author = {Zhang, Ding and Xie, Yunfei and Liao, Qi and Jiao, Zhe and Liang, Rui and Zhang, Jintao and Zhang, Yu and Tan, Yubei and Wang, Huanbin and Zhang, Wanpo and Xiao, Shaobo and Peng, Guiqing and Shi, Yuejun},
  title = {Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {11},
  doi = {10.1128/jvi.00429-24}
}
Kostenlos starten →